CORD-19:005c43980edf3fcc2a4d12ee7ad630ddb651ce6e / 17907-18057
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/005c43980edf3fcc2a4d12ee7ad630ddb651ce6e","sourcedb":"CORD-19","sourceid":"005c43980edf3fcc2a4d12ee7ad630ddb651ce6e","text":"Further study was performed with diluents of 50-fold and 70-fold of QD650-conjugated anti-H5 HA and QD580conjugated anti-influenza A NP, respectively.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T107","span":{"begin":0,"end":150},"obj":"Sentence"},{"id":"TextSentencer_T107","span":{"begin":0,"end":150},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T107","pred":"source","obj":"CORD-19-Sentences"},{"subj":"TextSentencer_T107","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T41","span":{"begin":121,"end":130},"obj":"Disease"},{"id":"T18930","span":{"begin":121,"end":130},"obj":"Disease"}],"attributes":[{"id":"A41","pred":"mondo_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A62671","pred":"mondo_id","subj":"T18930","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"subj":"T41","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T18930","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#df93ec","default":true},{"id":"CORD-19-PD-MONDO","color":"#93ecc5"}]}]}}